U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. Exhibit 4-4 long description
  1. Prescription Drug User Fee Amendments

Exhibit 4-4 long description

The total number of issues identified prior to first action in Pilot 1 products (n=6) was 50 versus 55 issues in the comparison cohort (n=8). The issues identified prior to first action by category were, CMC: 20 issues in Pilot 1 versus 23 in the comparison cohort; Efficacy: 15 issues in pilot 1 versus 17 in the comparison cohort; and Safety: 15 issues in Pilot 1 versus 16 in the comparison cohort.

Back to Top